Check out MJNA GREAT NEWS yesterday! Print

New Post Public Reply Private Reply Replies (0) Message Board
Lets Roll

Check out MJNA GREAT NEWS yesterday!

Medical Marijuana, Inc." (PC) (USOTC:MJNA)
Intraday Stock Chart

Today : Wednesday 15 August 2012

Click Here for more Medical Marijuana, Inc." (PC) Charts.
Medical Marijuana, Inc. Closes with Lotus Capital for a $2 Million Equity Based Line of Credit

PR Newswire

SAN DIEGO , Aug. 14, 2012 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA) a leading hemp industry innovator, has announced that the Company has signed closing documentation for a $2 million USD line of credit with Lotus Capital, a Chicago based private equity firm. The line of credit will be used as a reserve fund for product expansion of the Dixie X line of Cannabidoil (CBD) based products as well as to support the national marketing campaign of the Dixie X and CanChew gum product launch, scheduled for early September.  The LOC will also be available to support future expansion through Company acquisitions.

This new revolving line of credit will be secured against shares of the Company's Capital Stock. MJNA is in the process of providing a new S-1 registration statement for the issuance of the shares. Additional terms of the LOC allow MJNA to cancel the line at any time, releasing the security interest in the shares back to the Company. This transaction is non-dilutive to the shareholders providing that the Company repays any drawdown against the LOC per the terms of the agreement.

Revolving Line of Credit Uses

Currently, Company revenue sources are sufficient to meet operational cash-flow requirements. However, the Company anticipates increased costs to properly support the national launch of its hemp-based CBD Dixie-X and CanChew products. Additionally, we have numerous product and market expansion opportunities which require capital to execute. For these reasons, the Company has been exploring several financing options.

Medical Marijuana, Inc. President Michael Llamas was quoted: "Having this additional access to the capital markets gives us maximum flexibility to bring forth the best of the numerous business opportunities that lie before us.  Although we have been extremely selective in our current business development , we foresee numerous potential expansion opportunities and want to be prepared for the future. We appreciate the continued support of our team and shareholders."

Company to become Fully Reporting

In conjunction with the S-1 filing, MJNA expects to file their first audited financial statements prior to year-end. The Company's objective is to complete the 15c2-11 application process, which it started in May of this year, as well as becoming a fully reporting, fully compliant company with the Securities Exchange Commission (SEC).  The audit and due diligence process will take an additional 90 to 120 days to complete. Once completed and approved, the Company's equity shares will trade on a "Solicited" basis, be on a higher level of the NASD Over-the-Counter Bulletin Board and there will be a dedicated market maker for the Company's tradable shares.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana, Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visit the company's website at: www.MedicalMarijuanaInc.com

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Corporate Contact:Medical Marijuana, Inc. Toll Free : 888-OTC-MJNA (888-682-6562)

www.medicalmarijuanainc.com www.facebook.com/mjnainc

Investor Relations Contact: Stuart T. Smith SmallCapVoice.Com, Inc.P. 512-267-2430F. 512-267-2530Email: ssmith@smallcapvoice.com Skype: SmallCapVoice.comAIM: SmallCapVoice7

SOURCE Medical Marijuana, Inc.

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 308

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 243

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 462

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 303

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 421

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 594

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 547

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 505

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading

Top 5 Most Recently Viewed Articles

Shuttle Pharma Sets Stage With Major $5.75 Million Offering

Updated Category News Views 118

Shuttle Pharma Secures $5.75 Million in Public Offering Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) has made an impactful announcement that reflects its commitment to advancing cancer treatment. The company, recognized for its innovative approach to enhancing the efficacy of radiation therapy for cancer patients, has confirmed the pricing of its latest public...

Continue Reading
Innovative B2B Marketplace Development Announced by INNO Holdings

Updated Category News Views 133

Strategic Partnership Announcement INNO HOLDINGS INC. (“INNO” or the “Company”) (NASDAQ: INHD), a prominent player in the technology and electronic products trading sector, proudly unveils its strategic collaboration with New Life Technology Development Co Ltd (“New Life Tech”). This innovative partnership aims to revolutionize the B2B marketplace platform, a...

Continue Reading
Thomasville Bancshares, Inc. Celebrates Milestone Growth in 2024

Updated Category News Views 145

Strong Financial Performance Marks 2024 for Thomasville Bancshares Thomasville Bancshares, Inc. (OTC PINK: THVB), which serves as the parent company for Thomasville National Bank and TNB Financial Services, has reported impressive financial results for the year ending December 31, 2024. The company demonstrated remarkable growth and solid financial health, underlining its...

Continue Reading
EchoStar's Earnings Anticipation: Insights and Stock Analysis

Updated Category News Views 138

EchoStar's Earnings Predictions EchoStar (NASDAQ: SATS) is preparing for its quarterly earnings announcement, and investors are keenly awaiting the details. As this announcement approaches, it's essential to understand the key financial metrics and expectations to guide investment decisions. Understanding EPS Estimates Analysts project that EchoStar will report an...

Continue Reading
Luminary Labs Secures Contract to Enhance Federal Innovations

Updated Category News Views 155

Luminary Labs Secures Contract to Enhance Federal Innovations Luminary Labs, a strategy and innovation consultancy, has been awarded a prestigious contract under OASIS+ Small Business. This "Best-in-Class" contract vehicle is designed to simplify access for federal clients seeking strategic partnerships. The contract reveals Luminary Labs' commitment and expertise in...

Continue Reading